Neurosense Therapeutics Ltd (NRSN)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $3.21M
Last updated: Nov 17, 2026 at 11:00 AM ET
Earnings
Performance (10Y)
Upcoming Estimates
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the price is 59.2% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 31.4, in the neutral range between 30 and 70.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Performance
Related GNG Research
No research available
Be the first to write about NRSN
GNG News
All NRSN newsNews
NRSN Valuation
- P/B
- -1.5x
NRSN Profitability: Margins, ROIC and FCF
Neurosense Therapeutics (NRSN) has an operating margin of 0.0% and a net margin of 0.0%.
- Operating margin
- 0.0%
- Net margin
- 0.0%
- ROE
- -2175.0%
Neurosense Therapeutics Competitors
The companies most similar to Neurosense Therapeutics (NRSN) include Senti Biosciences, CNS Pharmaceuticals and Reviva Pharmaceuticals Holdings.
Sector: Healthcare
NRSN Analyst Ratings
Neurosense Therapeutics (NRSN) has a Buy consensus from 3 analysts: 2 Buy or Strong Buy, 1 Hold and 0 Sell or Strong Sell.
- Consensus
- Buy
- Analysts
- 3
- Strong Buy
- 0
- Buy
- 2
- Hold
- 1
- Sell
- 0
- Strong Sell
- 0
NRSN Bull Case vs Bear Case
Bull case
- NRSN beat EPS estimates in 75.0% of its last 8 reported quarters.
NRSN Earnings: Beat Rate
The next report from Neurosense Therapeutics (NRSN) is expected on Mar 29, 2027.
- Beat rate
- 6 of 8 quarters (75.0%)
- Average surprise
- 24.6%
NRSN Earnings Date
NRSN reports Mar 29, 2027. The date is estimated.
Updated Oct 27, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About NRSN
When does NRSN report earnings?
Neurosense Therapeutics Ltd (NRSN) is expected to report earnings on Mar 29, 2027.
Does NRSN pay dividends?
Neurosense Therapeutics Ltd (NRSN) does not currently pay a regular dividend.
What is NRSN's market cap?
Neurosense Therapeutics Ltd (NRSN) has a market capitalization of $3.21M with a current stock price of $1.69.
How do analysts rate NRSN stock?
3 analysts cover Neurosense Therapeutics Ltd (NRSN): 0 rate it Strong Buy, 2 Buy, 1 Hold, 0 Sell and 0 Strong Sell, a consensus of Buy.
NRSN pages: Overview, Financials
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.